Luye Pharma Group (FRA:LUP) Other Long-Term Liabilities : €45.7 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Luye Pharma Group Other Long-Term Liabilities?

Luye Pharma Group's other long-term liabilities for the quarter that ended in Dec. 2024 was €45.7 Mil.

Luye Pharma Group's quarterly other long-term liabilities declined from Dec. 2023 (€76.0 Mil) to Jun. 2024 (€70.6 Mil) and declined from Jun. 2024 (€70.6 Mil) to Dec. 2024 (€45.7 Mil).

Luye Pharma Group's annual other long-term liabilities declined from Dec. 2022 (€196.9 Mil) to Dec. 2023 (€76.0 Mil) and declined from Dec. 2023 (€76.0 Mil) to Dec. 2024 (€45.7 Mil).

Luye Pharma Group Other Long-Term Liabilities Historical Data

The historical data trend for Luye Pharma Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luye Pharma Group Other Long-Term Liabilities Chart

Luye Pharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

39.24

218.04

196.87

76.04

45.66

Luye Pharma Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial															196.87	75.85	76.04	70.60	45.66

Luye Pharma Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Luye Pharma Group Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Luye Pharma Group's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Luye Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luye Pharma Group Ltd (FRA:LUP) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

LYPHF:USA 02186:Hong Kong

Address

Hongqiao Road 1438, 22/F, Gubei International Fortune Center II, Changning District, Shanghai, CHN, 264003

Website

https://www.luye.cn

Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company's highest revenue share comes from oncology drugs, followed by central nervous system drugs. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, Cardiovascular system drugs, Alimentary tract and metabolism drugs, Central nervous system drugs and others. It derives maximum revenue from the sale of Oncology drugs.

Luye Pharma Group Headlines

No Headlines